Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

Cell Stem Cell

Volumn 10, Issue 3, 2012, Pages 244-258

  Ranganath, Sudhir H ^a,b,c,d,e   Levy, Oren ^b,c,d   Inamdar, Maneesha S ^a,e   Karp, Jeffrey M ^b,c,d  

^a JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

^e TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STEM CELL FACTOR;

ANTIBODY DETECTION; APOPTOSIS; BIODEGRADATION; BIOINFORMATICS; CARDIOVASCULAR DISEASE; CELL HOMING; CELL STRUCTURE; CELLULAR STRESS RESPONSE; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; HEART MUSCLE; HEART MUSCLE NECROSIS; HUMAN; ISCHEMIC PRECONDITIONING; LIQUID CHROMATOGRAPHY; MESENCHYMAL STEM CELL SECRETOME; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROARRAY ANALYSIS; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TISSUE REPAIR;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; GENE EXPRESSION PROFILING; HUMANS; IMMUNOMODULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; PARACRINE COMMUNICATION;

EID: 84857838864     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2012.02.005     Document Type: Review

References (123)

1. M.R. Afzal, H.Kh. Haider, N.M. Idris, S. Jiang, R.P. Ahmed, and M. Ashraf Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling Antioxid. Redox Signal. 12 2010 693 702
2. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822 (Pubitemid 40223708)
3. J. Ankrum, and J.M. Karp Mesenchymal stem cell therapy: Two steps forward, one step back Trends Mol. Med. 16 2010 203 209
4. A.C.M. Assis, J.L. Carvalho, B.A. Jacoby, R.L.B. Ferreira, P. Castanheira, S.O.F. Diniz, V.N. Cardoso, A.M. Goes, and A.J. Ferreira Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart Cell Transplant. 19 2010 219 230
5. T.J. Bartosh, J.H. Ylöstalo, A. Mohammadipoor, N. Bazhanov, K. Coble, K. Claypool, R.H. Lee, H. Choi, and D.J. Prockop Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties Proc. Natl. Acad. Sci. USA 107 2010 13724 13729
6. V. Bassaneze, V.G. Barauna, C. Lavini-Ramos, J. Kalil, I.T. Schettert, A.A. Miyakawa, and J.E. Krieger Shear stress induces nitric oxide-mediated vascular endothelial growth factor production in human adipose tissue mesenchymal stem cells Stem Cells Dev. 19 2010 371 378
7. A.P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, S. Chimenti, H. Kasahara, M. Rota, E. Musso, and K. Urbanek Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776 (Pubitemid 37186770)
8. N. Beohar, J. Rapp, S. Pandya, and D.W. Losordo Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease J. Am. Coll. Cardiol. 56 2010 1287 1297
9. M.F. Berry, A.J. Engler, Y.J. Woo, T.J. Pirolli, L.T. Bish, V. Jayasankar, K.J. Morine, T.J. Gardner, D.E. Discher, and H.L. Sweeney Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance Am. J. Physiol. Heart Circ. Physiol. 290 2006 H2196 H2203
10. C. Berthonneche, T. Sulpice, F. Boucher, L. Gouraud, J. de Leiris, S.E. O'Connor, J.M. Herbert, and P. Janiak New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats Am. J. Physiol. Heart Circ. Physiol. 287 2004 H340 H350
11. S. Biswas, P.K. Ghoshal, S.C. Mandal, and N. Mandal Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction Korean J. Intern. Med. 25 2010 44 50
12. G.J. Block, S. Ohkouchi, F. Fung, J. Frenkel, C. Gregory, R. Pochampally, G. DiMattia, D.E. Sullivan, and D.J. Prockop Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1 Stem Cells 27 2009 670 681
13. P. Carmeliet VEGF as a key mediator of angiogenesis in cancer Oncology 69 Suppl 3 2005 4 10 (Pubitemid 41680947)
14. E. Chavakis, M. Koyanagi, and S. Dimmeler Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back Circulation 121 2010 325 335
15. Z.K. Cheng, L.L. Ou, X. Zhou, F. Li, X.H. Jia, Y.G. Zhang, X.L. Liu, Y.M. Li, C.A. Ward, L.G. Melo, and D. Kong Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance Mol. Ther. 16 2008 571 579 (Pubitemid 351314998)
16. P.R. Crisostomo, Y. Wang, T.A. Markel, M. Wang, T. Lahm, and D.R. Meldrum Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism Am. J. Physiol. Cell Physiol. 294 2008 C675 C682
17. J. Croitoru-Lamoury, F.M.J. Lamoury, J.J. Zaunders, L.A. Veas, and B.J. Brew Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone J. Interferon Cytokine Res. 27 2007 53 64 (Pubitemid 46185062)
18. M.E. Danoviz, J.S. Nakamuta, F.L.N. Marques, L. dos Santos, E.C. Alvarenga, A.A. dos Santos, E.L. Antonio, I.T. Schettert, P.J. Tucci, and J.E. Krieger Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention PLoS ONE 5 2010 e12077
19. M. Debrunner, E. Schuiki, E. Minder, E. Straumann, B. Naegeli, R. Mury, O. Bertel, and J. Frielingsdorf Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock Clin. Res. Cardiol. 97 2008 298 305 (Pubitemid 351725055)
20. M.G. Engelmann, H.D. Theiss, C. Hennig-Theiss, A. Huber, B.J. Wintersperger, A.E. Werle-Ruedinger, S.O. Schoenberg, G. Steinbeck, and W.M. Franz Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial J. Am. Coll. Cardiol. 48 2006 1712 1721 (Pubitemid 44528196)
21. S.E. Epstein, R. Kornowski, S. Fuchs, and H.F. Dvorak Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects Circulation 104 2001 115 119 (Pubitemid 32623299)
22. F.A. Fierro, S. Kalomoiris, C.S. Sondergaard, and J.A. Nolta Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy Stem Cells 29 2011 1727 1737
23. M. Franois, R. Romieu-Mourez, M. Li, and J. Galipeau Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation Mol. Ther. 20 2012 187 195
24. M. Gnecchi, H.M. He, O.D. Liang, L.G. Melo, F. Morello, H. Mu, N. Noiseux, L.N. Zhang, R.E. Pratt, J.S. Ingwall, and V.J. Dzau Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells Nat. Med. 11 2005 367 368 (Pubitemid 40562318)
25. M. Gnecchi, H.M. He, N. Noiseux, O.D. Liang, L.M. Zhang, F. Morello, H. Mu, L.G. Melo, R.E. Pratt, J.S. Ingwall, and V.J. Dzau Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J. 20 2006 661 669 (Pubitemid 44933310)
26. M. Gnecchi, Z.P. Zhang, A.G. Ni, and V.J. Dzau Paracrine mechanisms in adult stem cell signaling and therapy Circ. Res. 103 2008 1204 1219
27. A.F.G. Godier-Furnémont, T.P. Martens, M.S. Koeckert, L. Wan, J. Parks, K. Arai, G.P. Zhang, B. Hudson, S. Homma, and G. Vunjak-Novakovic Composite scaffold provides a cell delivery platform for cardiovascular repair Proc. Natl. Acad. Sci. USA 108 2011 7974 7979
28. J.Y. Hahn, H.J. Cho, H.J. Kang, T.S. Kim, M.H. Kim, J.H. Chung, J.W. Bae, B.H. Oh, Y.B. Park, and H.S. Kim Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction J. Am. Coll. Cardiol. 51 2008 933 943
29. H.Kh. Haider, S. Jiang, N.M. Idris, and M. Ashraf IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair Circ. Res. 103 2008 1300 1308
30. J.M. Hare, J.H. Traverse, T.D. Henry, N. Dib, R.K. Strumpf, S.P. Schulman, G. Gerstenblith, A.N. DeMaria, A.E. Denktas, and R.S. Gammon A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J. Am. Coll. Cardiol. 54 2009 2277 2286
31. K.E. Hatzistergos, H. Quevedo, B.N. Oskouei, Q.H. Hu, G.S. Feigenbaum, I.S. Margitich, R. Mazhari, A.J. Boyle, J.P. Zambrano, and J.E. Rodriguez Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation Circ. Res. 107 2010 913 922
32. T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, F.J. Giordano, M. Simons, D.W. Losordo, R.C. Hendel, R.O. Bonow, and S.M. Eppler Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease Am. Heart J. 142 2001 872 880 (Pubitemid 33016208)
33. T.D. Henry, B.H. Annex, G.R. McKendall, M.A. Azrin, J.J. Lopez, F.J. Giordano, P.K. Shah, J.T. Willerson, R.L. Benza, D.S. Berman VIVA Investigators The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis Circulation 107 2003 1359 1365 (Pubitemid 36350732)
34. J.L. Herrmann, Y. Wang, A.M. Abarbanell, B.R. Weil, J.N. Tan, and D.R. Meldrum Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection Shock 33 2010 24 30
35. J.L. Herrmann, B.R. Weil, A.M. Abarbanell, Y. Wang, J.A. Poynter, M.C. Manukyan, and D.R. Meldrum IL-6 and TGF-α costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms Shock 35 2011 512 516
36. J. Huang, Z. Zhang, J. Guo, A. Ni, A. Deb, L. Zhang, M. Mirotsou, R.E. Pratt, and V.J. Dzau Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium Circ. Res. 106 2010 1753 1762
37. J.E. Ip, Y.J. Wu, J. Huang, L.N. Zhang, R.E. Pratt, and V.J. Dzau Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment Mol. Biol. Cell 18 2007 2873 2882 (Pubitemid 47235295)
38. Y. Iso, J.L. Spees, C. Serrano, B. Bakondi, R. Pochampally, Y.H. Song, B.E. Sobel, P. Delafontaine, and D.J. Prockop Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment Biochem. Biophys. Res. Commun. 354 2007 700 706 (Pubitemid 46186241)
39. T. Kamota, T.S. Li, N. Morikage, M. Murakami, M. Ohshima, M. Kubo, T. Kobayashi, A. Mikamo, Y. Ikeda, M. Matsuzaki, and K. Hamano Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase J. Am. Coll. Cardiol. 53 2009 1814 1822
40. S. Kanki, V.F.M. Segers, W.T. Wu, R. Kakkar, J. Gannon, S.U. Sys, A. Sandrasagra, and R.T. Lee Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium Circ. Heart Fail 4 2011 509 518
41. J.M. Karp, and G.S. Leng Teo Mesenchymal stem cell homing: the devil is in the details Cell Stem Cell 4 2009 206 216
42. T. Kinnaird, E. Stabile, M.S. Burnett, C.W. Lee, S. Barr, S. Fuchs, and S.E. Epstein Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ. Res. 94 2004 678 685 (Pubitemid 38387752)
43. T. Kinnaird, E. Stabile, M.S. Burnett, M. Shou, C.W. Lee, S. Barr, S. Fuchs, and S.E. Epstein Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms Circulation 109 2004 1543 1549 (Pubitemid 38420184)
44. B. Kühn, F. del Monte, R.J. Hajjar, Y.S. Chang, D. Lebeche, S. Arab, and M.T. Keating Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair Nat. Med. 13 2007 962 969 (Pubitemid 47222046)
45. M.A. Laflamme, and C.E. Murry Regenerating the heart Nat. Biotechnol. 23 2005 845 856 (Pubitemid 43093128)
46. R.H. Lee, A.A. Pulin, M.J. Seo, D.J. Kota, J. Ylostalo, B.L. Larson, L. Semprun-Prieto, P. Delafontaine, and D.J. Prockop Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 Cell Stem Cell 5 2009 54 63
47. M.J. Lee, J. Kim, M.Y. Kim, Y.S. Bae, S.H. Ryu, T.G. Lee, and J.H. Kim Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells J. Proteome Res. 9 2010 1754 1762
48. M. Leiker, G. Suzuki, V.S. Iyer, J.M. Canty Jr., and T. Lee Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells Cell Transplant. 17 2008 911 922
49. H.X. Li, S. Zuo, Z.S. He, Y.T. Yang, Z. Pasha, Y.G. Wang, and M.F. Xu Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival Am. J. Physiol. Heart Circ. Physiol. 299 2010 H1772 H1781
50. C.P. Liu, J.L. Yeh, B.N. Wu, C.Y. Chai, I.J. Chen, and W.T. Lai KMUP-3 attenuates ventricular remodelling after myocardial infarction through eNOS enhancement and restoration of MMP-9/TIMP-1 balance Br. J. Pharmacol. 162 2011 126 135
51. F.S. Loffredo, M.L. Steinhauser, J. Gannon, and R.T. Lee Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair Cell Stem Cell 8 2011 389 398
52. T.P. Lozito, and R.S. Tuan Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs J. Cell. Physiol. 226 2011 385 396
53. A.A. Mangi, N. Noiseux, D.L. Kong, H.M. He, M. Rezvani, J.S. Ingwall, and V.J. Dzau Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts Nat. Med. 9 2003 1195 1201 (Pubitemid 37173705)
54. R. Matsumoto, T. Omura, M. Yoshiyama, T. Hayashi, S. Inamoto, K.R. Koh, K. Ohta, Y. Izumi, Y. Nakamura, and K. Akioka Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction Arterioscler. Thromb. Vasc. Biol. 25 2005 1168 1173 (Pubitemid 40776604)
55. S. Matsumura, S. Iwanaga, S. Mochizuki, H. Okamoto, S. Ogawa, and Y. Okada Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice J. Clin. Invest. 115 2005 599 609 (Pubitemid 40322234)
56. R. Mazhari, and J.M. Hare Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche Nat. Clin. Pract. Cardiovasc. Med. 4 Suppl 1 2007 S21 S26
57. C. Mias, E. Trouche, M.H. Seguelas, F. Calcagno, F. Dignat-George, F. Sabatier, M.D. Piercecchi-Marti, L. Daniel, P. Bianchi, and D. Calise Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney Stem Cells 26 2008 1749 1757
58. M. Mirotsou, Z.Y. Zhang, A. Deb, L.N. Zhang, M. Gnecchi, N. Noiseux, H. Mu, A. Pachori, and V. Dzau Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair Proc. Natl. Acad. Sci. USA 104 2007 1643 1648 (Pubitemid 46214644)
59. M. Mirotsou, T.M. Jayawardena, J. Schmeckpeper, M. Gnecchi, and V.J. Dzau Paracrine mechanisms of stem cell reparative and regenerative actions in the heart J. Mol. Cell. Cardiol. 50 2011 280 289
60. Y. Miyahara, N. Nagaya, M. Kataoka, B. Yanagawa, K. Tanaka, H. Hao, K. Ishino, H. Ishida, T. Shimizu, and K. Kangawa Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction Nat. Med. 12 2006 459 465
61. C. Moro, M.G. Jouan, A. Rakotovao, M.C. Toufektsian, O. Ormezzano, N. Nagy, A. Tosaki, J. de Leiris, and F. Boucher Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling Am. J. Physiol. Heart Circ. Physiol. 293 2007 H3014 H3019
62. N. Nagaya, K. Kangawa, T. Itoh, T. Iwase, S. Murakami, Y. Miyahara, T. Fujii, M. Uematsu, H. Ohgushi, and M. Yamagishi Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy Circulation 112 2005 1128 1135 (Pubitemid 41216119)
63. C. Nakanishi, M. Yamagishi, K. Yamahara, I. Hagino, H. Mori, Y. Sawa, T. Yagihara, S. Kitamura, and N. Nagaya Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells Biochem. Biophys. Res. Commun. 374 2008 11 16
64. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 110 2007 3499 3506 (Pubitemid 350159613)
65. K. Németh, A. Leelahavanichkul, P.S.T. Yuen, B. Mayer, A. Parmelee, K. Doi, P.G. Robey, K. Leelahavanichkul, B.H. Koller, and J.M. Brown Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production Nat. Med. 15 2009 42 49
66. B.K. Nguyen, S. Maltais, L.P. Perrault, J.F. Tanguay, J.C. Tardif, L.M. Stevens, M. Borie, F. Harel, S. Mansour, and N. Noiseux Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors J. Cardiovasc. Transl. Res. 3 2010 547 558
67. N. Noiseux, M. Gnecchi, M. Lopez-Ilasaca, L. Zhang, S.D. Solomon, A. Deb, V.J. Dzau, and R.E. Pratt Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation Mol. Ther. 14 2006 840 850 (Pubitemid 44752717)
68. S. Ohnishi, T. Yasuda, S. Kitamura, and N. Nagaya Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells Stem Cells 25 2007 1166 1177 (Pubitemid 46684876)
69. A. Oskowitz, H. McFerrin, M. Gutschow, M.L. Carter, and R. Pochampally Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic Stem Cell Res. (Amst.) 6 2011 215 225
70. M.E. Padin-Iruegas, Y. Misao, M.E. Davis, V.F.M. Segers, G. Esposito, T. Tokunou, K. Urbanek, T. Hosoda, M. Rota, and P. Anversa Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction Circulation 120 2009 876 887
71. H.L. Pahl Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 1999 6853 6866
72. B. Parekkadan, D. van Poll, K. Suganuma, E.A. Carter, F. Berthiaume, A.W. Tilles, and M.L. Yarmush Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure PLoS ONE 2 2007 e941
73. C.W. Park, K.-S. Kim, S. Bae, H.K. Son, P.-K. Myung, H.J. Hong, and H. Kim Cytokine secretion profiling of human mesenchymal stem cells by antibody array Int. J. Stem Cells 2 2009 59 68
74. Z. Pasha, Y. Wang, R. Sheikh, D. Zhang, T. Zhao, and M. Ashraf Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium Cardiovasc. Res. 77 2008 134 142 (Pubitemid 351195153)
75. I.A. Potapova, G.R. Gaudette, P.R. Brink, R.B. Robinson, M.R. Rosen, I.S. Cohen, and S.V. Doronin Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro Stem Cells 25 2007 1761 1768 (Pubitemid 47121855)
76. I.A. Potapova, P.R. Brink, I.S. Cohen, and S.V. Doronin Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells J. Biol. Chem. 283 2008 13100 13107
77. D.J. Prockop, and J.Y. Oh Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation Mol. Ther. 20 2012 14 20
78. P.J. Psaltis, S. Paton, F. See, A. Arthur, S. Martin, S. Itescu, S.G. Worthley, S. Gronthos, and A.C.W. Zannettino Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations J. Cell. Physiol. 223 2010 530 540
79. Y. Rattigan, J.M. Hsu, P.J. Mishra, J. Glod, and D. Banerjee Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu Exp. Cell Res. 316 2010 3417 3424
80. R.S. Ripa, E. Jørgensen, Y.Z. Wang, J.J. Thune, J.C. Nilsson, L. Søndergaard, H.E. Johnsen, L. Køber, P. Grande, and J. Kastrup Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial Circulation 113 2006 1983 1992
81. M. Rodrigues, L.G. Griffith, and A. Wells Growth factor regulation of proliferation and survival of multipotential stromal cells Stem Cell Res. Ther. 1 2010 32
82. D. Sarkar, J.A. Ankrum, G.S.L. Teo, C.V. Carman, and J.M. Karp Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms Biomaterials 32 2011 3053 3061
83. D. Sarkar, J.A. Spencer, J.A. Phillips, W. Zhao, S. Schafer, D.P. Spelke, L.J. Mortensen, J.P. Ruiz, P.K. Vemula, and R. Sridharan Engineered cell homing Blood 118 2011 e184 e191
84. F.J. Schoen The Heart V. Kumar, A. Abbas, N. Fausto, Robbins and Cotran Pathologic Basis of Disease Seventh Edition 2007 Reed Elsevier India Pvt Ltd New Delhi, India 577 579
85. V.F.M. Segers, T. Tokunou, L.J. Higgins, C. MacGillivray, J. Gannon, and R.T. Lee Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 116 2007 1683 1692 (Pubitemid 47537842)
86. F.P. Seib, M. Prewitz, C. Werner, and M. Bornhäuser Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs) Biochem. Biophys. Res. Commun. 389 2009 663 667
87. A. Shabbir, D. Zisa, G. Suzuki, and T. Lee Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1888 H1897
88. M. Shi, J. Li, L. Liao, B. Chen, B. Li, L. Chen, H. Jia, and R.C. Zhao Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice Haematologica 92 2007 897 904 (Pubitemid 350144236)
89. R.Z. Shi, J.C. Wang, S.H. Huang, X.J. Wang, and Q.P. Li Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells Exp. Cell Res. 315 2009 10 15
90. J.M. Singelyn, and K.L. Christman Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices J. Cardiovasc. Transl. Res. 3 2010 478 486
91. H. Skalnikova, J. Motlik, S.J. Gadher, and H. Kovarova Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines Proteomics 11 2011 691 708
92. B.R. Son, L.A. Marquez-Curtis, M. Kucia, M. Wysoczynski, A.R. Turner, J. Ratajczak, M.Z. Ratajczak, and A. Janowska-Wieczorek Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases Stem Cells 24 2006 1254 1264 (Pubitemid 44464694)
93. H. Song, M.J. Cha, B.W. Song, I.K. Kim, W. Chang, S. Lim, E.J. Choi, O. Ham, S.Y. Lee, and N. Chung Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex Stem Cells 28 2010 555 563
94. S.K. Sze, D.P.V. de Kleijn, R.C. Lai, E. Khia Way Tan, H. Zhao, K.S. Yeo, T.Y. Low, Q. Lian, C.N. Lee, and W. Mitchell Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells Mol. Cell. Proteomics 6 2007 1680 1689 (Pubitemid 350031670)
95. Y.L. Tang, Q. Zhao, X.Y. Qin, L.P. Shen, L.L. Cheng, J.B. Ge, and M.I. Phillips Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction Ann. Thorac. Surg. 80 2005 229 236 discussion 236-237
96. J.M. Tang, J.N. Wang, L.Y. Guo, X. Kong, J.Y. Yang, F. Zheng, L. Zhang, and Y.Z. Huang Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction Mol. Cells 29 2010 9 19
97. J.V. Terrovitis, R.R. Smith, and E. Marbán Assessment and optimization of cell engraftment after transplantation into the heart Circ. Res. 106 2010 479 494
98. L. Timmers, S.K. Lim, I.E. Hoefer, F. Arslan, R.C. Lai, A.A.M. van Oorschot, M.J. Goumans, C. Strijder, S.K. Sze, and A. Choo Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction Stem Cell Res. (Amst.) 6 2011 206 214
99. C. Toma, M.F. Pittenger, K.S. Cahill, B.J. Byrne, and P.D. Kessler Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 2002 93 98 (Pubitemid 34049148)
100. K. Urbanek, M. Rota, S. Cascapera, C. Bearzi, A. Nascimbene, A. De Angelis, T. Hosoda, S. Chimenti, M. Baker, and F. Limana Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival Circ. Res. 97 2005 663 673 (Pubitemid 41416335)
101. M. Valgimigli, G.M. Rigolin, C. Cittanti, P. Malagutti, S. Curello, G. Percoco, A.M. Bugli, M. Della Porta, L.Z. Bragotti, and L. Ansani Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile Eur. Heart J. 26 2005 1838 1845 (Pubitemid 41253295)
102. S. Van Linthout, K. Savvatis, K. Miteva, J. Peng, J. Ringe, K. Warstat, C. Schmidt-Lucke, M. Sittinger, H.P. Schultheiss, and C. Tschöpe Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis Eur. Heart J. 32 2011 2168 2178
103. D. van Poll, B. Parekkadan, I.H.M. Borel Rinkes, A.W. Tilles, and M.L. Yarmush Mesenchymal stem cell therapy for protection and repair of injured vital organs Cell Mol. Bioeng. 1 2008 42 50
104. R.S. Velagaleti, M.J. Pencina, J.M. Murabito, T.J. Wang, N.I. Parikh, R.B. D'Agostino, D. Levy, W.B. Kannel, and R.S. Vasan Long-term trends in the incidence of heart failure after myocardial infarction Circulation 118 2008 2057 2062
105. J. Wang, P. Paradis, A. Aries, H. Komati, C. Lefebvre, H. Wang, and M. Nemer Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4 Mol. Cell. Biol. 25 2005 9829 9844 (Pubitemid 41572733)
106. M.J. Wang, P.R. Crisostomo, C. Herring, K.K. Meldrum, and D.R. Meldrum Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 2006 R880 R884
107. M.J. Wang, W.J. Zhang, P. Crisostomo, T. Markel, K.K. Meldrum, X.Y. Fu, and D.R. Meldrum STAT3 mediates bone marrow mesenchymal stem cell VEGF production J. Mol. Cell. Cardiol. 42 2007 1009 1015 (Pubitemid 46829204)
108. Y. Wang, B.R. Weil, J.L. Herrmann, A.M. Abarbanell, J.N. Tan, T.A. Markel, M.L. Kelly, and D.R. Meldrum MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells Am. J. Physiol. Cell Physiol. 297 2009 C1284 C1293
109. Y. Wang, A.M. Abarbanell, J.L. Herrmann, B.R. Weil, M.C. Manukyan, J.A. Poynter, and D.R. Meldrum TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection PLoS ONE 5 2010 e14206
110. R.S. Waterman, S.L. Tomchuck, S.L. Henkle, and A.M. Betancourt A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype PLoS ONE 5 2010 e10088
111. M.J. Webber, X. Han, S.N. Murthy, K. Rajangam, S.I. Stupp, and J.W. Lomasney Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases J. Tissue Eng. Regen. Med. 4 2010 600 610
112. B.R. Weil, M.C. Manukyan, J.L. Herrmann, Y. Wang, A.M. Abarbanell, J.A. Poynter, and D.R. Meldrum Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia Surgery 148 2010 444 452
113. A.R. Williams, and J.M. Hare Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease Circ. Res. 109 2011 923 940
114. S. Wisel, M. Khan, M.L. Kuppusamy, I.K. Mohan, S.M. Chacko, B.K. Rivera, B.C. Sun, K. Hideg, and P. Kuppusamy Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression J. Pharmacol. Exp. Ther. 329 2009 543 550
115. K.C. Wollert, and H. Drexler Cell therapy for the treatment of coronary heart disease: a critical appraisal Nat. Rev. Cardiol. 7 2010 204 215
116. World Health Organization (2011). The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/index.html.
117. H.S. Xu, B.A. Yi, and K.R. Chien Shortcuts to making cardiomyocytes Nat. Cell Biol. 13 2011 191 193
118. H. Yagi, A. Soto-Gutierrez, N. Navarro-Alvarez, Y. Nahmias, Y. Goldwasser, Y. Kitagawa, A.W. Tilles, R.G. Tompkins, B. Parekkadan, and M.L. Yarmush Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1 Mol. Ther. 18 2010 1857 1864
119. Y.J. Yang, H.Y. Qian, J. Huang, Y.J. Geng, R.L. Gao, K.F. Dou, G.S. Yang, J.J. Li, R. Shen, and Z.X. He Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts Eur. Heart J. 29 2008 1578 1590 (Pubitemid 351881977)
120. F. Yang, S.W. Cho, S.M. Son, S.R. Bogatyrev, D. Singh, J.J. Green, Y. Mei, S. Park, S.H. Bhang, and B.S. Kim Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles Proc. Natl. Acad. Sci. USA 107 2010 3317 3322
121. Y.W. Yao, F.M. Zhang, L.S. Wang, G.H. Zhang, Z.J. Wang, J.M. Chen, and X. Gao Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction J. Biomed. Sci. 16 2009 74
122. T.-L. Yew, Y.-T. Hung, H.-Y. Li, H.-W. Chen, L.-L. Chen, K.-S. Tsai, S.-H. Chiou, K.-C. Chao, T.-F. Huang, H.-L. Chen, and S.C. Hung Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation Cell Transplant. 20 2011 693 706
123. K. Yu, J. Ge, J.B. Summers, F. Li, X. Liu, P. Ma, J. Kaminski, and J. Zhuang TSP-1 secreted by bone marrow stromal cells contributes to retinal ganglion cell neurite outgrowth and survival PLoS ONE 3 2008 e2470